Performance-linked stock acquisition rights for directors and employees
First written in FY2018-Q2. 22 of 24 entries say "Advanced", first in FY2018-Q3. Latest entry: 2026-07-31.
30 other companies' latest entry also says "Advanced".
- FY2026-H1AdvancedAnnual report
「1 September 2025 to 28 February 2026 (Note) 28,200 13,709,100 10,528 322,962 10,528 235,112 Between 1 March 2026 and 31 March 2026, the number of issued shares increased by 900 shares through the exercise of stock acquisition rights.」
The exercise of performance-linked stock acquisition rights increased the number of issued shares by 28,200 during the current interim consolidated accounting period and by a further 900 shares in March 2026. - FY2025-H1AdvancedAnnual report
「Between 1 March 2025 and 31 March 2025, the number of issued shares increased by 400 shares through the exercise of stock acquisition rights.」
The exercise of performance-linked stock acquisition rights during March 2025 increased the number of issued shares by 400. - FY2024AdvancedAnnual report
「Ninth Series of Stock Acquisition Rights (approved at an extraordinary meeting of the Board of Directors on 18 January 2024)」
The Company issued the Ninth Series of Stock Acquisition Rights to 62 Company employees and 1 subsidiary employee, with 131,400 shares remaining unvested. The exercise period runs from 1 February 2026 to 31 January 2032, and achievement of phased revenue and ordinary profit targets is an exercise condition. - FY2024-Q3AdvancedAnnual report
「Between 1 June 2024 and 30 June 2024, the total number of issued shares increased by 400 shares, while stated capital and capital surplus each increased by ¥139 thousand, through the exercise of stock acquisition rights.」
The exercise of performance-linked stock acquisition rights during June 2024, after the end of the quarter, increased the number of issued shares by 400. - FY2024-Q2AdvancedAnnual report
「Between 1 March 2024 and 31 March 2024, the number of issued shares increased by 3,700 shares through the exercise of stock acquisition rights.」
The exercise of performance-linked stock acquisition rights during March 2024, after the end of the quarter, increased the number of issued shares by 3,700. - FY2024-Q1AdvancedAnnual report
「Between 1 December 2023 and 31 December 2023, the number of issued shares increased by 5,800 shares through the exercise of stock acquisition rights.」
The exercise of performance-linked stock acquisition rights during December 2023 increased the number of issued shares by 5,800. - FY2023AdvancedAnnual report
「For the stock options outstanding during the fiscal year ended August 2023, the unexercised balance after vesting was 30,900 shares for the Fifth Series Stock Acquisition Rights, 13,300 shares for the Sixth Series, and 44,700 shares for the Seventh Series.」
For the performance-linked stock acquisition rights, the vested and unexercised balances for the Fifth through Seventh Series have been updated in detail. - FY2023-Q2AdvancedAnnual report
「1 December 2022 to 28 February 2023 (Note) 34,400 13,988,400 774 307,006 774 219,156」
The exercise of stock acquisition rights increased the number of issued shares by 34,400 between December 2022 and February 2023. The Third and Fourth Series Stock Acquisition Rights expired upon the expiration of their exercise period on 31 December 2022. - FY2023-Q1AdvancedAnnual report
「Between 1 December 2022 and 31 December 2022, the number of issued shares increased by 34,400 shares through the exercise of stock acquisition rights.」
The exercise of performance-linked stock acquisition rights during December 2022 increased the number of issued shares by 34,400. - FY2022AdvancedAnnual report
「Eighth Series of Stock Acquisition Rights (approved at an extraordinary meeting of the Board of Directors on 15 February 2022)」
The Company issued the Eighth Series of Stock Acquisition Rights to 54 Company employees and 3 subsidiary employees. The exercise period runs from 1 March 2024 to 28 February 2030, and achievement of phased revenue and ordinary profit targets is an exercise condition. - FY2022-Q3AdvancedAnnual report
「Between 1 June 2022 and 30 June 2022, the number of issued shares increased by 14,000 shares through the exercise of stock acquisition rights.」
The filing states that the exercise of performance-linked stock acquisition rights during June 2022 increased the number of issued shares by 14,000. - FY2022-Q2AdvancedAnnual report
「Between 1 March 2022 and 31 March 2022, the number of issued shares increased by 2,000 shares through the exercise of stock acquisition rights.」
The exercise of performance-linked stock acquisition rights during March 2022, after the end of the quarter, increased the number of issued shares by 2,000. - FY2022-Q1AdvancedAnnual report
「Between 1 December 2021 and 31 December 2021, the number of issued shares increased by 35,600 shares through the exercise of stock acquisition rights.」
The exercise of performance-linked stock acquisition rights during December 2021, before the filing date, increased the number of issued shares by 35,600. - FY2021-Q3AdvancedAnnual report
「Increase or decrease in total number of issued shares 16,800 (Note) Increase resulting from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights between 1 March and 31 May 2021 increased the number of issued shares by 16,800. - FY2021-Q2AdvancedAnnual report
「Between 1 March 2021 and 31 March 2021, the number of issued shares increased by 17,200 shares through the exercise of stock acquisition rights.」
The filing states that 17,200 shares were added through exercise of the performance-linked stock acquisition rights during the period through the filing date. - FY2021-Q1AdvancedAnnual report
「Between 1 December 2020 and 31 December 2020, the number of issued shares increased by 50,800 shares through the exercise of stock acquisition rights.」
The filing states that the performance-linked stock acquisition rights were exercised during December 2020, before the filing date, increasing the number of issued shares by 50,800. - FY2020AdvancedAnnual report
「At a meeting of its Board of Directors held on 6 August 2020, the Company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue the Seventh Series of Stock Acquisition Rights (the "Stock Acquisition Rights") to its employees and the directors and employees of its subsidiaries, and issued them on 24 August 2020.」
The Company issued 184,500 Seventh Series Stock Acquisition Rights to directors, employees and subsidiary employees. The exercise conditions are linked to revenue and ordinary profit targets for the fiscal years ending August 2021 through August 2027. - FY2019-Q3AdvancedAnnual report
「At a meeting of its Board of Directors held on 14 February 2019, the Company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue the Sixth Series of Stock Acquisition Rights (the "Stock Acquisition Rights") to its employees and the directors and employees of its subsidiaries, and issued them on 5 March 2019.」
The Company issued 755 Sixth Series Stock Acquisition Rights, representing 75,500 underlying shares, to 25 Company employees, 1 subsidiary director and 3 subsidiary employees. The exercise period runs from 1 March 2021 to 28 February 2027, and performance targets are an exercise condition. - FY2019-Q1AdvancedAnnual report
「Between 1 December 2018 and 31 December 2018, the number of issued shares increased by 7,200 shares through the exercise of stock acquisition rights.」
The filing states that 7,200 shares were added through exercise of the performance-linked stock acquisition rights during the period through the filing date. - FY2018RestatedAnnual report
「(a) If revenue of ¥20 billion and ordinary profit of ¥2 billion are achieved in any fiscal year from the fiscal year ending August 2019 through the fiscal year ending August 2025: Exercisable percentage 30%」
The exercise conditions linked to revenue and ordinary profit from the fiscal year ending August 2019 through the fiscal year ending August 2025 continue to be disclosed for the Fifth Series of Stock Acquisition Rights for directors and employees. - FY2018-Q3AdvancedAnnual report
「Number of stock acquisition rights 1,562 Number of shares underlying the stock acquisition rights 156,200 Exercise period for the stock acquisition rights 1 March 2020 to 28 February 2026 (Note) Increase resulting from the exercise of stock acquisition rights.」
For the performance-linked stock acquisition rights, the number of outstanding rights and underlying shares has been updated, and the exercise of stock acquisition rights is also identified as a factor contributing to the increase in issued shares. - FY2018-Q2First statedAnnual report
「At a meeting of its Board of Directors held on 15 February 2018, the Company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue the Fifth Series of Stock Acquisition Rights (the "Stock Acquisition Rights") to its directors and employees, and issued them on 5 March 2018.」
The Company issued 1,583 stock acquisition rights, representing 158,300 underlying shares, to 1 director and 63 employees. The exercise period runs from 1 March 2020 to 28 February 2026, and achievement of phased revenue and ordinary profit targets is an exercise condition.